Understanding the problems in pharmaceutical procurement with special reference to active pharmaceutical ingredients and excipients

被引:0
作者
Zauwad Alam
Sukhbir Kaur
Pawan Kumar Porwal
机构
[1] ISF College of Pharmacy,Incompatibility Study Division & Analytical Laboratory (ISFAL), Department of Quality Assurance
[2] Amity University Madhya Pradesh,Amity Institute of Pharmacy (AIP)
来源
Accreditation and Quality Assurance | 2018年 / 23卷
关键词
Pharmaceutical procurement; Active pharmaceutical ingredient; Regulatory requirements; User requirement specifications; Vendor certification procedure;
D O I
暂无
中图分类号
学科分类号
摘要
Procurement of raw materials, key intermediates and excipients for the preparation of finished pharmaceutical preparation is considered to be complex process which involve multiple channels and require skilled personnel and proper validation. This review attempts, in relatively brief compass to provide an account of the problems that arise while procurement of active pharmaceutical ingredient (API) and excipients in pharmaceutical industry. This review has been structured with specified as well as generalized problems raised up during procurement of API and other material in pharmaceutical industry. Lack of proper regulatory requirements and unbiased market information with the absence of a comprehensive procurement policy is the major factor which creates complications while procurement. Besides these, lack of properly designed user requirement specifications (URS) which ultimately affect quality and delivery of quoted material. An 8-Question-based approach has been proposed to design URS, other approaches for material procurement and supplier qualification have been discussed, and a vendor certification procedure is presented.
引用
收藏
页码:319 / 328
页数:9
相关论文
共 104 条
  • [1] Talluri S(2002)A buyer–seller game model for selection and negotiation of purchasing bids Eur J Oper Res 143 171-180
  • [2] Kannan VR(2003)Attitudes of US and European managers to supplier selection and assessment and implications for business performance Benchmarking Int J 10 472-489
  • [3] Tan KC(1996)An analysis of vendor selection systems and decisions J Purchasing 2 28-41
  • [4] Dickson G(1990)Vendor performance and alternative manufacturing environments Decis Sci 21 403-415
  • [5] Benton WC(1994)Contracting out health services in developing countries Health Policy Plan 9 25-30
  • [6] Krajeski L(2009)The influence of a collaborative procurement approach using integrated design in construction on project team performance Int J Manag Projects Bus 2 370-385
  • [7] McPake B(1988)Excipients-standards, tests and functionality Eur Pharm Rev 1 19-22
  • [8] Ngalande-Bande E(1989)Managing vendor performance Prod Invent Manag J 30 1-7
  • [9] Forgues D(2006)A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials J Pharm Biomed Anal 41 1251-1259
  • [10] Koskela L(2006)Guidance for industry on chemistry, manufacturing, and controls information; withdrawal and revision of seven guidance Fed Reg 71 31194-31195